Liu B - Search Results

1

Development of a highly stable and targetable nanoliposomal formulation of topotecan.

Drummond DC, Noble CO, Guo Z, Hayes ME, Connolly-Ingram C, Gabriel BS, Hann B, Liu B, Park JW, Hong K, Benz CC, Marks JD, Kirpotin DB. Drummond DC, et al. Among authors: liu b. J Control Release. 2010 Jan 4;141(1):13-21. doi: 10.1016/j.jconrel.2009.08.006. Epub 2009 Aug 15. J Control Release. 2010. PMID: 19686789

2

Applying phage antibodies to proteomics: selecting single chain Fv antibodies to antigens blotted on nitrocellulose.

Liu B, Marks JD. Liu B, et al. Anal Biochem. 2000 Nov 1;286(1):119-28. doi: 10.1006/abio.2000.4788. Anal Biochem. 2000. PMID: 11038282

3

Towards proteome-wide production of monoclonal antibody by phage display.

Liu B, Huang L, Sihlbom C, Burlingame A, Marks JD. Liu B, et al. J Mol Biol. 2002 Feb 1;315(5):1063-73. doi: 10.1006/jmbi.2001.5276. J Mol Biol. 2002. PMID: 11827476 Free article.

4

Mapping tumor epitope space by direct selection of single-chain Fv antibody libraries on prostate cancer cells.

Liu B, Conrad F, Cooperberg MR, Kirpotin DB, Marks JD. Liu B, et al. Cancer Res. 2004 Jan 15;64(2):704-10. doi: 10.1158/0008-5472.can-03-2732. Cancer Res. 2004. PMID: 14744788

5

Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.

Goenaga AL, Zhou Y, Legay C, Bougherara H, Huang L, Liu B, Drummond DC, Kirpotin DB, Auclair C, Marks JD, Poul MA. Goenaga AL, et al. Among authors: liu b. Mol Immunol. 2007 Jul;44(15):3777-88. doi: 10.1016/j.molimm.2007.03.023. Epub 2007 May 10. Mol Immunol. 2007. PMID: 17498801 Free PMC article.

6

Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer.

Liu B, Conrad F, Roth A, Drummond DC, Simko JP, Marks JD. Liu B, et al. J Mol Med (Berl). 2007 Oct;85(10):1113-23. doi: 10.1007/s00109-007-0208-z. Epub 2007 Jun 7. J Mol Med (Berl). 2007. PMID: 17554518

7

Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells.

Roth A, Drummond DC, Conrad F, Hayes ME, Kirpotin DB, Benz CC, Marks JD, Liu B. Roth A, et al. Among authors: liu b. Mol Cancer Ther. 2007 Oct;6(10):2737-46. doi: 10.1158/1535-7163.MCT-07-0140. Mol Cancer Ther. 2007. PMID: 17938267

8

Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies.

An F, Drummond DC, Wilson S, Kirpotin DB, Nishimura SL, Broaddus VC, Liu B. An F, et al. Among authors: liu b. Mol Cancer Ther. 2008 Mar;7(3):569-78. doi: 10.1158/1535-7163.MCT-07-2132. Epub 2008 Mar 4. Mol Cancer Ther. 2008. PMID: 18319332 Free PMC article.

9

Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion.

Conrad F, Zhu X, Zhang X, Chalkley RJ, Burlingame AL, Marks JD, Liu B. Conrad F, et al. Among authors: liu b. J Mol Med (Berl). 2009 May;87(5):507-14. doi: 10.1007/s00109-009-0446-3. Epub 2009 Feb 14. J Mol Med (Berl). 2009. PMID: 19219419 Free PMC article.

10

An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors.

McCabe KE, Liu B, Marks JD, Tomlinson JS, Wu H, Wu AM. McCabe KE, et al. Among authors: liu b. Mol Imaging Biol. 2012 Jun;14(3):336-47. doi: 10.1007/s11307-011-0500-8. Mol Imaging Biol. 2012. PMID: 21630083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36,430 results

Search Page